Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study

BACKGROUND: The original aim of this study was to evaluate the treatment sequence and anthracycline requirement in docetaxel, cyclophosphamide and trastuzumab therapy. After one death in the anthracycline-containing arm, the protocol was amended to terminate the randomization. The single-docetaxel,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Takayuki, Masuda, Norikazu, Sato, Nobuaki, Ohtani, Shoichiro, Yamamura, Jun, Matsunami, Nobuki, Kashiwaba, Masahiro, Takano, Toshimi, Takahashi, Masato, Kaneko, Koji, Ohno, Shinji, Morita, Satoshi, Toi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978625/
https://www.ncbi.nlm.nih.gov/pubmed/31821506
http://dx.doi.org/10.1093/jjco/hyz119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978625/
https://www.ncbi.nlm.nih.gov/pubmed/31821506
http://dx.doi.org/10.1093/jjco/hyz119

Ejemplares similares